Insider trades
Moore Paul Andrew, Chief Officer of Zymeworks ZYME, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $721.5K. The latest trade was on 01/12.
Moore Paul Andrew
Chief Scientific Officer
- Company
- Zymeworks ZYME
- First filing
- 23/01/06
- Trades
- 28 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$721.5K
- Last trade
- 01/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ZymeworksZYME | Open-market sale | 01/12 | 01/12 | 9,560 sh | $22.67 | $216,725.2 | −16.5% |
ZYME | Open-market sale | 01/05 | 01/05 | 20,110 sh2 trades | $25.10avg. | $504,761 | −33.2% |
ZYME | Open-market sale | 25/01/06 | 25/01/06 | 21,200 sh2 trades | $14.92avg. | $316,304 | −47.6% |
ZYME | Open-market sale | 24/01/05–24/01/08 | 24/01/08 | 9,799 sh2 trades | $10.79avg. | $105,692.58 | −57.1% |